Inotiv, Inc. Balance Sheet | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Mar 31, 2026	Q1 FY2026 As of Dec 31, 2025	Q4 FY2025 As of Sep 30, 2025	Q3 FY2025 As of Jun 30, 2025	Q2 FY2025 As of Mar 31, 2025	Q1 FY2025 As of Dec 31, 2024	Q4 FY2024 As of Sep 30, 2024	Q3 FY2024 As of Jun 30, 2024	Q2 FY2024 As of Mar 31, 2024	Q1 FY2024 As of Dec 31, 2023	Q4 FY2023 As of Sep 30, 2023	Q3 FY2023 As of Jun 30, 2023	Q2 FY2023 As of Mar 31, 2023	Q1 FY2023 As of Dec 31, 2022	Q4 FY2022 As of Sep 30, 2022	Q3 FY2022 As of Jun 30, 2022	Q2 FY2022 As of Mar 31, 2022	Q1 FY2022 As of Dec 31, 2021	Q4 FY2021 As of Sep 30, 2021	Q3 FY2021 As of Jun 30, 2021
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Trade, net of allowance of $668 at September 30, 2021 and $561 at September 30, 2020
Unbilled revenues and other
Restricted Cash and Cash Equivalents
Trade receivables and contract assets, net of allowances for credit losses of $7,523 and $6,268, respectively
Trade receivables and contract assets, net of allowances for credit losses of $6,208 and $6,397, respectively
Inventories, net
Prepaid expenses
Prepaid expenses and other current assets
Assets held for sale
Total current assets

Property and equipment, net
Operating lease right-of-use assets, net
Finance lease right-of-use assets, net
Goodwill
Other intangible assets, net
Lease rent receivable
Other assets
Total assets

Liabilities and shareholders' equity
Current liabilities:
Accounts payable
Restructuring liability
Accrued expenses and other current liabilities
Current portion of contingent liability
Capex line of credit
Revolving credit facility
Fees invoiced in advance
Current portion of long-term operating lease
Current portion of long-term finance lease
Current portion of long-term debt
Liabilities held for sale
Total current liabilities

Long-term operating leases, net
Long-term finance leases, net
Long-term portion of contingent liability
Long-Term Debt, Excluding Current Maturities
Other long-term liabilities
Deferred tax liabilities, net
Total liabilities
Common Stock, No Par Value
Shareholders’ equity:
Preferred shares, authorized 1,000,000 shares, no par value:
Authorized 74,000,000 shares at March 31, 2026 and at September 30, 2025; 34,888,147 issued and outstanding at March 31, 2026 and 34,357,251 at September 30, 2025
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Total equity
Noncontrolling interest
Total shareholders’ equity and noncontrolling interest

Total liabilities and shareholders’ equity

Common stock authorized (in shares)

Comments